The U.S. Food and Drug Administration (FDA) has issued a statement that Teva Pharmaceuticals USA has initiated a voluntary nationwide recall of a single lot of Anagrelide Capsules, USP 0.5 mg (Lot number GD01090), to the consumer level in the United States.
News | Pharmaceuticals
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules

May 24, 2022 — The U.S. Food and Drug Administration (FDA) has issued a statement that Teva Pharmaceuticals USA has ...

Home May 24, 2022
Home
Developed in collaboration with Janssen and Mayo Clinic, this technology has the potential to aid physicians in earlier detection of pulmonary hypertension, a progressive, life-threatening disease
News | Artificial Intelligence
FDA Grants Breakthrough Device Designation to Anumana’s ECG Pulmonary Hypertension Early Detection AI Algorithm

May 24, 2022 — Anumana, Inc., an AI-driven health technology company from nference, Inc., today announced that the U.S ...

Home May 24, 2022
Home
A specific protein in blood vessel cells plays a major role in the development of vascular and cardiovascular diseases: The presence of too many "thromboxane A2 receptors" hinders the formation of new blood vessels.
News | Cardiovascular Clinical Studies
Researchers Find New Approach to Treating Cardiovascular Diseases

May 23, 2022 — A specific protein in blood vessel cells plays a major role in the development of vascular and ...

Home May 23, 2022
Home
New data from a study of more than 100 million hospitalizations using machine learning augmentation was presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions.
News | Cardio-oncology
Nationwide Study of 100 Million Hospitalizations Finds Percutaneous Coronary Intervention is Safe for Cardio-oncology Patients

May 23, 2022 — New data from a study of more than 100 million hospitalizations using machine learning augmentation was ...

Home May 23, 2022
Home
Percutaneous coronary interventions remain below pre-pandemic levels
News | STEMI
Nationwide Study Finds Significant Decline in Treatment for Heart Attacks During Pandemic

May 23, 2022 — New findings from the Ascension Health System’s internal National Cardiovascular Data Registry (NCDR) ...

Home May 23, 2022
Home
Nationwide study points to implicit bias in treatment of cardiovascular disease for non-Hispanic Black patients and highlights need for equity
News | Heart Failure
Racial Disparities Seen in Treatment for Patients with Acute Coronary Syndrome and History of Cocaine Use

May 23, 2022 — Insights from a National Inpatient Sample Database examining race and the rates of cardiac ...

Home May 23, 2022
Home
Findings underscore need to examine social factors that impact healthcare outcomes for most vulnerable
News | STEMI
New Study Finds Low-income Patients at Higher Risk of Death After Heart Attack

May 20, 2022 — Results from a retrospective analysis reveal significantly higher mortality rates for low-income ...

Home May 20, 2022
Home
First study to compare safety and eficacy of clopidogrel and aspirin monotherapy beyond 12 months in high-risk PCI population
News | Cardiovascular Clinical Studies
Long-term Use of Clopidogrel Monotherapy Associated with Lower Patient Risk Compared to Aspirin Motherapy

May 20, 2022 — Results from a real-world study investigating safety and effectiveness of clopidogrel versus aspirin ...

Home May 20, 2022
Home
Multi-center study explores new treatment for heart failure patients with preserved and reduced ejection fraction
News | Heart Failure
No-implant Interatrial Shunt Device to Treat Heart Failure Patients Reveals Promising Multi-center Clinical Data

May 20, 2022 — Results from early clinical evaluation of the Alleviant System to treat heart failure patients with ...

Home May 20, 2022
Home
New Analysis Shows the Evolution of Intervention Techniques in Chronic Total Occlusion Patients
News | Chronic Total Occlusion (CTO)
International Chronic Total Occlusion Percutaneous Coronary Intervention Registry Finds Increasing Procedural Success

May 20, 2022 — A new analysis of PROGRESS-CTO (PROspective Global REgiStry for the Study of Chronic Total Occlusion ...

Home May 20, 2022
Home
Three years ago a study raised concerns that paclitaxel-coated devices may cause increased mortality in peripheral artery disease patients. However, numerous studies now show there is no risk of increased mortality. The most recent study is the SAFE-PAD study presented at SCAI22.
News | Peripheral Artery Disease (PAD)
New Longterm Data of Paclitaxel Devices Continues to Show No Increased Mortality Compared to Non-drug Coated Devices

May 20, 2022 — New long-term data from the Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel ...

Home May 20, 2022
Home
Abbott TriClip G4 device
News | Structural Heart
New Late-Breaking Data Highlight Abbott Structural Heart Transcatheter Valve Therapies

May 20, 2022 — Abbott announced two late-breaking data presentations highlighting both TriClip, a first-of-its kind ...

Home May 20, 2022
Home
The Medtronic Harmony transcatheter pulmonary valve (TPV) system offers a less invasive treatment option for patients with a congenital heart defect irregularity in their right ventricular outflow tract (RVOT) that requires a pulmonary valve placement to restore valve function. 
News | Heart Valve Technology
First Intermediate to Long-term Study of the Harmony Transcatheter Pulmonary Valve System Validates Safety and Efficacy

May 19, 2022 — A study of 1-year outcomes in the largest cohort to date of Harmony transcatheter pulmonary valve (TPV) ...

Home May 19, 2022
Home
First multi-center, randomized controlled study provides the largest long-term evidence for the treatment of heavily calcified femoropopliteal lesions
News | Peripheral Artery Disease (PAD)
Disrupt PAD III Trial Demonstrates Safety and Effectiveness of Intravascular Lithotripsy for Peripheral Artery Calcification

May 19, 2022 — One year outcomes from the Disrupt PAD III Trial comparing intravascular lithotripsy (IVL) with a drug ...

Home May 19, 2022
Home
The latest analysis from The North American COVID-19 STEMI (NACMI) was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions.
News | STEMI
International COVID-19 Registry Finds Significant Increased Risk of In-hospital Mortality for STEMI Patients with COVID-19 Compared to Pre-pandemic

May 19, 2022 — The latest analysis from The North American COVID-19 STEMI (NACMI) was presented today as late-breaking ...

Home May 19, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now